Yasin Keshvargar
Lawyers
Filters
Ablynx NV $230 Million U.S. Initial Public Offering of ADSs and Listing on the NASDAQ
Davis Polk advised the representatives of the several underwriters in connection with Ablynx NV’s offering of $230 million of its ordinary shares in the form of American Depositary…
Advanced Accelerator Applications $3.9 billion acquisition by Novartis
Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…
Davis Polk Advises GeoPark Limited on Its $425 Million Notes Offering and Cash Tender Offer
Davis Polk advised GeoPark Limited in connection with the offering of $425 million aggregate principal amount of its 6.500% senior secured notes due 2024. The notes were sold in an…
Davis Polk Advises Banco de Bogotá S.A. on Its $600 Million Global Senior Notes Offering
Davis Polk advised Banco de Bogotá S.A. in connection with its global offering of $600 million aggregate principal amount of its 4.375% senior notes due 2027, pursuant to Rule 144A and…
XPO Logistics, Inc. $665.5 Million Common Stock Offering and Forward Sale Agreements
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 11,000,000 shares of common stock of XPO Logistics, Inc. and advised the…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Callon Petroleum Company $200 Million Senior Notes Reopening
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $200 million aggregate principal amount of Callon Petroleum Company’s…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 7,000,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Davis Polk Advises Murphy USA on Its $300 Million Notes Offering
Davis Polk advised Murphy USA Inc. in connection with an SEC-registered offering of $300 million aggregate principal amount of 5.625% senior notes due 2027. The notes were issued by Murphy…
Evolent Health Common Stock Secondary Offering
Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…